Anterix Inc. (NASDAQ:ATEX) CEO Robert Harris Schwartz Sells 11,512 Shares

Anterix Inc. (NASDAQ:ATEX) CEO Robert Harris Schwartz sold 11,512 shares of the stock in a transaction dated Monday, September 20th. The stock was sold at an average price of $56.28, for a total value of $647,895.36. Following the transaction, the chief executive officer now owns 144,606 shares of the company’s stock, valued at $8,138,425.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Robert Harris Schwartz also recently made the following trade(s):

  • On Thursday, September 16th, Robert Harris Schwartz sold 22,922 shares of Anterix stock. The shares were sold at an average price of $56.59, for a total value of $1,297,155.98.
  • On Tuesday, September 14th, Robert Harris Schwartz sold 10,505 shares of Anterix stock. The shares were sold at an average price of $58.07, for a total value of $610,025.35.

Shares of NASDAQ ATEX opened at $57.34 on Tuesday. Anterix Inc. has a 12 month low of $27.26 and a 12 month high of $64.96. The stock has a 50 day moving average of $58.55 and a 200-day moving average of $52.83. The company has a market capitalization of $1.04 billion, a P/E ratio of -19.64 and a beta of 0.46.

Anterix (NASDAQ:ATEX) last issued its earnings results on Tuesday, August 10th. The company reported ($0.67) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.63) by ($0.04). Anterix had a negative return on equity of 23.61% and a negative net margin of 6,051.24%. The business had revenue of $0.18 million for the quarter, compared to the consensus estimate of $0.18 million. On average, equities analysts predict that Anterix Inc. will post -2.13 EPS for the current fiscal year.

A number of research analysts have weighed in on ATEX shares. Morgan Stanley raised their price target on Anterix from $51.00 to $65.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 4th. B. Riley restated a “buy” rating on shares of Anterix in a research note on Wednesday, June 9th. Finally, JPMorgan Chase & Co. lifted their target price on Anterix from $50.00 to $60.00 and gave the stock an “overweight” rating in a research note on Thursday, June 17th. One research analyst has rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $62.50.

Several hedge funds and other institutional investors have recently modified their holdings of ATEX. Advisor Group Holdings Inc. acquired a new stake in Anterix during the 2nd quarter worth approximately $33,000. Nisa Investment Advisors LLC lifted its holdings in Anterix by 290.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,075 shares of the company’s stock worth $64,000 after purchasing an additional 800 shares during the last quarter. Emerald Advisers LLC acquired a new stake in Anterix during the 2nd quarter worth approximately $66,000. Metropolitan Life Insurance Co NY lifted its holdings in Anterix by 74,875.0% during the 2nd quarter. Metropolitan Life Insurance Co NY now owns 2,999 shares of the company’s stock worth $180,000 after purchasing an additional 2,995 shares during the last quarter. Finally, Paloma Partners Management Co acquired a new stake in Anterix during the 2nd quarter worth approximately $203,000. Institutional investors own 83.95% of the company’s stock.

Anterix Company Profile

Anterix, Inc operates as a wireless communications company. The firm focuses on commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks, technologies and solutions. It’s solutions include Private LTE and Active Ecosystem. The company was founded by Peter Joel Lasensky and Richard Edward Rohmann in 1997 and is headquartered in Woodland Park, NJ.

Recommended Story: What is included in the gross domestic product?

Insider Buying and Selling by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.